Hallucinations, delusions, and noctural events in 152 Parkinson's patients: A regional survey;Hallucinations, idées délirantes, événements nocturnes chez 152 patients atteints de maladie de Parkinson. Enquête régionale

Revue Neurologique

Volumn 158, Issue 2, 2002, Pages 203-210

  Bailbe M ^a   Karolewicz, S ^a   Neau, J Ph ^a   Dumas, P ^a   Gil, R ^a   Bourgoin, B ^a   Le Bras, F ^a   Daviaud, J ^a   Devauchelle, H ^a   Devoize, J L ^a   Latinville, D ^a   De Liege P ^a   Loll, P Y ^a   Marcombes, J L ^a   Marty, F ^a   Maufreron, J B ^a   Pin, J C ^a   Vincent, D ^a   Zai L ^a  

^a University of Poitiers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; FEMALE; HALLUCINATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DELUSIONS; FEMALE; FRANCE; HALLUCINATIONS; HEALTH SURVEYS; HUMANS; INPATIENTS; LEVODOPA; MALE; MIDDLE AGED; OUTPATIENTS; PARANOID DISORDERS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 0036198986     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study
2. Hallucinations, REM sleep, and Parkinson's disease a hypothesis
3. De l'insanité dans la paralysie agitante, (1882)
4. Behavioral complications of drug treatment in Parkinson's disease
5. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors
6. Hallucinations and parkinsonian motor fluctuations
7. Levodopa-induced psychosis in patients with idiopathic Parkinson disease
8. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
9. Hallucinosis in idiopathic Parkinson's disease
10. Parkinsonism: Onset, progression and mortality
11. Auditory hallucinations in Parkinson's disease
12. The specificity of neuroleptic and methysergide-induced behavioral hypersensitivity
13. The night-time problems of Parkinson's disease
14. Sleep disruption in the course of chronic levodopa therapy: An early feature of the levodopa psychosis
15. A clinical profile
16. Arguments en faveur du traitement précoce pour la maladie de Parkinson par les agonistes dopaminergiques
17. Dream phenomena induced by chronic levodopa therapy
18. Hallucinations in Parkinson's disease: A population study
19. Complications of disease and therapy: A comparison of younger and older patients with Parkinson's disease